D-0177-2021 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- January 6, 2021
- Initiation Date
- December 17, 2020
- Termination Date
- August 23, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6520 vials
Product Description
Dexamethasone - Moxifloxacin PF Injection (1/5) mg/mL, Imprimis Rx Volume: 1mL/vial, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ - 07852 (844)446-6979
Reason for Recall
Lack of assurance of sterility: 13 vials were discovered to have faulty crimps.
Distribution Pattern
U.S.A. Nationwide
Code Information
Lot#: 20JUN010, Exp 5/12/21